Privia Health Group, Inc.
Privia Health Group, Inc. Fundamental Analysis
Privia Health Group, Inc. (PRVA) shows weak financial fundamentals with a PE ratio of 130.98, profit margin of 0.97%, and ROE of 0.01%. The company generates $2.3B in annual revenue with strong year-over-year growth of 22.26%.
Key Strengths
Areas of Concern
The stock receives a Fundamental Health Score of 50.3/100 based on profitability, valuation, growth, and balance sheet metrics. The C grade reflects average fundamentals, with notable risks in certain areas.
Fundamental Health Score
We analyze PRVA's fundamental strength across five key dimensions:
Efficiency Score
WeakPRVA struggles to generate sufficient returns from assets.
Valuation Score
WeakPRVA trades at a premium to fair value.
Growth Score
ExcellentPRVA delivers strong and consistent growth momentum.
Financial Health Score
ExcellentPRVA maintains a strong and stable balance sheet.
Profitability Score
WeakPRVA struggles to sustain strong margins.
Key Financial Metrics
Is PRVA Expensive or Cheap?
P/E Ratio
PRVA trades at 130.98 times earnings. This suggests a premium valuation.
PEG Ratio
When adjusting for growth, PRVA's PEG of 3.41 indicates potential overvaluation.
Price to Book
The market values Privia Health Group, Inc. at 0.00 times its book value. This may indicate undervaluation.
EV/EBITDA
Enterprise value stands at 7888.49 times EBITDA. This signals the market has high growth expectations.
How Well Does PRVA Make Money?
Net Profit Margin
For every $100 in sales, Privia Health Group, Inc. keeps $0.97 as profit after all expenses.
Operating Margin
Core operations generate 1.62 in profit for every $100 in revenue, before interest and taxes.
ROE
Management delivers $0.01 in profit for every $100 of shareholder equity.
ROA
Privia Health Group, Inc. generates $0.00 in profit for every $100 in assets, demonstrating efficient asset deployment.
Following the Money - Real Cash Generation
Operating Cash Flow
Privia Health Group, Inc. generates limited operating cash flow of $140.07M, signaling weaker underlying cash strength.
Free Cash Flow
Privia Health Group, Inc. produces free cash flow of $138.82M, offering steady but limited capital for shareholder returns and expansion.
FCF Per Share
Each share generates $1.10 in free cash annually.
FCF Yield
PRVA converts 4.73% of its market value into free cash.
Financial Ratios Analysis
Valuation Ratios
P/E Ratio
Price to earnings ratio
130.98
vs 25 benchmark
PEG Ratio
Price/earnings to growth ratio
3.41
vs 25 benchmark
P/B Ratio
Price to book value ratio
0.004
vs 25 benchmark
P/S Ratio
Price to sales ratio
1.29
vs 25 benchmark
Financial Health
Debt/Equity
Total debt to shareholders' equity
0.01
vs 25 benchmark
Current Ratio
Current assets to current liabilities
1.61
vs 25 benchmark
Efficiency Ratios
ROE
Return on equity percentage
0.00
vs 25 benchmark
ROA
Return on assets percentage
0.00
vs 25 benchmark
ROCE
Return on capital employed
0.00
vs 25 benchmark
How PRVA Stacks Against Its Sector Peers
| Metric | PRVA Value | Sector Average | Performance |
|---|---|---|---|
| P/E Ratio | 130.98 | 28.62 | Worse (Expensive) |
| ROE | 0.01% | 783.00% | Weak |
| Net Margin | 0.97% | -44009.00% (disorted) | Weak |
| Debt/Equity | 0.01 | 0.39 | Strong (Low Leverage) |
| Current Ratio | 1.61 | 4.12 | Neutral |
| ROA | 0.00% | -21805.00% (disorted) | Weak |
PRVA outperforms its industry in 1 out of 6 key metrics, but lagging in P/E Ratio.
Historical Growth Performance
5-Year Growth Trajectory
This section reviews Privia Health Group, Inc.'s 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.
Revenue CAGR
124.79%
Industry Style: Defensive, Growth, Innovation
High GrowthEPS CAGR
-36.53%
Industry Style: Defensive, Growth, Innovation
DecliningFCF CAGR
263.53%
Industry Style: Defensive, Growth, Innovation
High Growth